Cardio-cerebral infarction
10.3760/cma.j.issn.1673-4165.2023.10.007
- VernacularTitle:心脑梗死
- Author:
Wenwu YANG
1
;
Xiaoli MIN
;
Sixian LIN
;
Lei XIAN
Author Information
1. 昆明医科大学第二附属医院脑血管病科，昆明 650101
- Keywords:
Ischemic stroke;
Myocardial infarction;
Thrombolytic therapy;
Endovascular procedures;
Thrombectomy;
Anticoagulants;
Platelet aggregation inhibitors;
Treatme
- From:
International Journal of Cerebrovascular Diseases
2023;31(10):762-767
- CountryChina
- Language:Chinese
-
Abstract:
Acute myocardial infarction (AMI) and acute ischemic stroke (AIS) are leading causes of death and disability in the world population. Cardio-cerebral infarction (CCI) is a rare clinical syndrome of AMI combined with AIS, which refers to the critical symptoms of simultaneous acute focal neurological deficits and precordial pain or electrocardiogram changes. The incidence of CCI ranges from 0.09% to 1.6%, but patients have a critical condition, poor prognosis, and high mortality and disability rates. Due to the complexity of the condition, diverse etiology, and limited evidence and mechanistic research, the management of patients with CCI is challenging. This article summarizes the pathogenesis related to CCI, the effectiveness of drug treatment, indications for endovascular treatment, and the selection of surgical sequence, with the aim of shortening thrombolysis/endovascular treatment time and improving outcomes of patients.
